Jonathan Schroer
About Jonathan Schroer
Jonathan Schroer is the Director of Global Patient Safety at BeiGene, with over fifteen years of experience in drug development and clinical pharmacy.
Current Position at BeiGene
Jonathan Schroer is currently serving as the Director of Global Patient Safety at BeiGene. In this role, he is responsible for overseeing patient safety functions and initiatives from his home office in the Orlando metro area. This position builds on his extensive experience in both clinical pharmacy and drug development, ensuring the safety and efficacy of biopharmaceutical products.
Previous Role at BeiGene
Before assuming his current role, Jonathan Schroer was the Associate Director of Global Patient Safety at BeiGene from 2018 to 2020, located in the San Francisco Bay Area. During this time, he contributed to the development and implementation of safety surveillance strategies for BeiGene's pharmaceutical products.
Experience at AbbVie
From 2015 to 2018, Jonathan Schroer worked at AbbVie as a Clinical Safety Surveillance and Risk Management Scientist. His responsibilities included risk management and the safety surveillance of clinical products, ensuring the minimization of risks to patients.
Clinical Pharmacist Roles
Jonathan Schroer has a diverse background in clinical pharmacy. He worked per diem as a Clinical Pharmacist at St. Joseph Health System from 2014 to 2022 in the San Francisco Bay Area. Additionally, he worked at CVS Health as a Community Pharmacist, also on a per diem basis, from 2012 to 2019. Earlier in his career, he worked as an Intern Pharmacist at the Indian Health Service and AIDS Healthcare Foundation, and a Student Pharmacist at UCSF.
Educational Background
Jonathan Schroer holds a Doctor of Pharmacy (PharmD) from the University of California, San Francisco, where he studied Pharmacy and Clinical Pharmacy from 2011 to 2015. He also earned a Master of Business Administration (MBA) from the University of Cincinnati College of Business from 2009 to 2011. Additionally, he achieved a Master of Science (MS) in Pharmaceutical Sciences with a specialization in Drug Development from the University of Cincinnati, studied from 2008 to 2014, and holds a BA, BPhil from Miami University.